Search

Your search keyword '"Segedi, Maja"' showing total 41 results

Search Constraints

Start Over You searched for: Author "Segedi, Maja" Remove constraint Author: "Segedi, Maja"
41 results on '"Segedi, Maja"'

Search Results

1. Combined portal and hepatic vein embolisation in perihilar cholangiocarcinoma

3. Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial

4. Clinical consensus statement: Establishing the roles of locoregional and systemic therapies for the treatment of intermediate-stage hepatocellular carcinoma in Canada

5. Outcomes of liver transplant recipients with high MELD scores: an experience from a Canadian centre

6. Prevention of postoperative pancreatic fistula after pancreatectomy: results of a Canadian RAND/UCLA appropriateness expert panel

13. Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas

17. Additional file 1 of Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial

18. Additional file 3 of Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial

19. Additional file 2 of Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial

27. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.

29. Major arterial resection for stage 3 adenocarcinoma of the pancreas.

30. Whipple procedure: patient selection and special considerations

33. Whipple procedure: patient selection and special considerations

34. BRM polymorphisms, pancreatic cancer risk and survival

35. A retrospective review of the University Health Network (UHN) multimodal treatment experience with extended resection of pancreatic ductal adenocarcinoma (PDAC) in patients with arterial involvement.

36. A 5-year review of surgical outcomes for deceased-donor liver transplantation in British Columbia.

38. Functional BRM promoter polymorphisms, pancreatic adenocarcinoma risk, and survival.

39. Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss (PRICE-2): a randomised controlled trial.

40. 2024 Canadian Surgery Forum: Sept. 25-28, 2024.

41. 2023 Canadian Surgery Forum: Sept. 20-23, 2023.

Catalog

Books, media, physical & digital resources